SC 13G Filing

Company

XTL BIOPHARMACEUTICALS LTD

Filed

September 18, 2007

Accession Number

0001193805-07-002410

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →